chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Pyrexia
Clinical narrative: Severe headache; Fever of 101.6; Chills; Fatigue; This is a spontaneous report from a contactable consumer, the parent. A 13-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 301308A) via an unspecified route of administration in the left arm on 18Sep2021 at 14:30 (at the age of 13-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and the known allergies were reported as "not that we knew". Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. It was reported that the patient was small for her age and the patient was mandated to get the shot by the school a week before the school started. The patient was healthy. On 19Sep2021 at 14:00, (also reported as 24 hours after vaccination), the patient experienced severe headache, fever of 101.6 (unspecified units), and also had symptoms related to the fever which were chills and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken for the events of fever 101.6 (unspecified units), chills, and fatigue (reported as managed fever). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe headache, fever of 101.6 (unspecified units), chills, and fatigue was recovering at the time of this report.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Erythema, Fatigue, Feeding disorder
Clinical narrative: Enlarged lymph nodes on left side of neck, clavicle and underarm; Red skin; Feeling very fatigue; Chills; Not feeling well at all; Cannot sleep; Heart rate is elevated; Feel dizzy at times; Headache; Nausea; Haven't been able to eat at all; This is a spontaneous report from a contactable nurse, the patient. A 51-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 18Sep2021 at 12:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 and known allergies to mussels and various face and body creams. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not take any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Sep2021 at 16:00, about 4 hours after the vaccination, the patient experienced headache and nausea. The patient still had both the events even 40 hours later. Since an unspecified date in Sep2021, the patient had not been able to eat at all. It was reported that since the night of 19Sep2021 (last night), the patient started to notice many enlarged lymph nodes on the left side of her neck, clavicle and underarm which was in the size of a walnut with red skin on top of them. The patient was feeling very fatigued, was having chills and was not feeling well at all and could not sleep. Also, on the same day, her heart rate was elevated and she felt dizzy at times. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, nausea, haven't been able to eat at all, enlarged lymph nodes on the left side of the neck, clavicle and underarm, red skin, feeling very fatigue, chills, not feeling well at all, cannot sleep, heart rate is elevated and feel dizzy at times was not resolved at the time of the report.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Heart rate, Heart rate increased, Insomnia, Lymphadenopathy
Clinical narrative: Enlarged lymph nodes on left side of neck, clavicle and underarm; Red skin; Feeling very fatigue; Chills; Not feeling well at all; Cannot sleep; Heart rate is elevated; Feel dizzy at times; Headache; Nausea; Haven't been able to eat at all; This is a spontaneous report from a contactable nurse, the patient. A 51-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 18Sep2021 at 12:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 and known allergies to mussels and various face and body creams. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not take any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Sep2021 at 16:00, about 4 hours after the vaccination, the patient experienced headache and nausea. The patient still had both the events even 40 hours later. Since an unspecified date in Sep2021, the patient had not been able to eat at all. It was reported that since the night of 19Sep2021 (last night), the patient started to notice many enlarged lymph nodes on the left side of her neck, clavicle and underarm which was in the size of a walnut with red skin on top of them. The patient was feeling very fatigued, was having chills and was not feeling well at all and could not sleep. Also, on the same day, her heart rate was elevated and she felt dizzy at times. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, nausea, haven't been able to eat at all, enlarged lymph nodes on the left side of the neck, clavicle and underarm, red skin, feeling very fatigue, chills, not feeling well at all, cannot sleep, heart rate is elevated and feel dizzy at times was not resolved at the time of the report.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Nausea
Clinical narrative: Enlarged lymph nodes on left side of neck, clavicle and underarm; Red skin; Feeling very fatigue; Chills; Not feeling well at all; Cannot sleep; Heart rate is elevated; Feel dizzy at times; Headache; Nausea; Haven't been able to eat at all; This is a spontaneous report from a contactable nurse, the patient. A 51-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 18Sep2021 at 12:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 and known allergies to mussels and various face and body creams. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not take any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Sep2021 at 16:00, about 4 hours after the vaccination, the patient experienced headache and nausea. The patient still had both the events even 40 hours later. Since an unspecified date in Sep2021, the patient had not been able to eat at all. It was reported that since the night of 19Sep2021 (last night), the patient started to notice many enlarged lymph nodes on the left side of her neck, clavicle and underarm which was in the size of a walnut with red skin on top of them. The patient was feeling very fatigued, was having chills and was not feeling well at all and could not sleep. Also, on the same day, her heart rate was elevated and she felt dizzy at times. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, nausea, haven't been able to eat at all, enlarged lymph nodes on the left side of the neck, clavicle and underarm, red skin, feeling very fatigue, chills, not feeling well at all, cannot sleep, heart rate is elevated and feel dizzy at times was not resolved at the time of the report.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Anosmia, SARS-CoV-2 test
Clinical narrative: Lost my sense of smell; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the arm left on 14Apr2021 at 10:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure (controlled). The patient had known allergies to SSKI (Potassium iodide). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 16Mar2021 at 16:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. On 17Apr2021, at 00:00 the patient experienced lost sense of smell. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had been tested for COVID-19. On 16Sep2021, the patient underwent nasal swab SAR-COV-2 TEST and the result was negative. The clinical outcome of the event lost sense of smell was resolving at the time of this report.
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Computerised tomogram, Magnetic resonance imaging, Seizure
Clinical narrative: seizures and went to the hospital; He is debilitated; This is a spontaneous report from a contactable consumer(parent). A 40-year-old male patient started to receive her second dose of BNT162B2 (COMIRNATY, solution for injection, Batch/Lot Number: Not reported) via an unspecified route of administration, administered on 15May2021 as DOSE 2, SINGLE for COVID-19 immunization. The patients medical history and concomitant medications were not reported. Historical vaccine included received his first dose of BNT162B2 (COMIRNATY, solution for injection, Batch/Lot Number: Not reported) on an unknown date via an unspecified route of administration, as DOSE 1, SINGLE for COVID-19 immunization. On an unknown date the caller stated that her son had severe side effects and can get no help. He's in the hospital now. After the second dose that he had seizures and went to the hospital and released and problems every since. He's had problems since May. He is debilitated. On an unknown date patient took MRIs and CATs in the hospital and the results were unknown. Outcome of the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Irritability, Neck pain
Clinical narrative: Very irritable; Severe shooting back pain/ lower back and upper back pain; Neck pain; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2588) via an unspecified route of administration in the left arm on 11Sep2021 at 17:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. The patient's medical history included no thyroid due to thyroid cancer, sulfa (sulfonamide) allergy and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The concomitant medications included lorazepam (MANUFACTURER UNKNOWN), liothyronine (MANUFACTURER UNKNOWN) and levothyroxine (MANUFACTURER UNKNOWN); all from an unknown date, for unknown indications and unknown if ongoing . The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Sep2021, the patient experienced severe shooting back pain with in one hour and for the next 3 days, with lower and upper back pain and on an unknown date in Sep2021 experienced neck pain which would not subside. Also, on 17Sep2021 at 18:30, the patient was very irritable. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe shooting back pain, lower and upper back pain and neck pain and very irritable were not resolved at the time of this report.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Oral discomfort, Oral disorder, Oropharyngeal pain, Stomatitis
Clinical narrative: Oral lesions; Blisters; Altered taste; Mouth burning; Raw mouth; Sore throat; Swollen tongue; This is a spontaneous report from a contactable nurse, the patient. A 37-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3183) via an unspecified route of administration on 06Sep2021 at 08:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 10Sep2021, the patient experienced oral lesions, blisters, altered taste, mouth burning, raw mouth, sore throat and swollen tongue. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included treatment with unspecified medications. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events oral lesions, blisters, altered taste, mouth burning, raw mouth, sore throat and swollen tongue was not resolved at the time of the report.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Swollen tongue, Taste disorder
Clinical narrative: Oral lesions; Blisters; Altered taste; Mouth burning; Raw mouth; Sore throat; Swollen tongue; This is a spontaneous report from a contactable nurse, the patient. A 37-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3183) via an unspecified route of administration on 06Sep2021 at 08:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 10Sep2021, the patient experienced oral lesions, blisters, altered taste, mouth burning, raw mouth, sore throat and swollen tongue. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included treatment with unspecified medications. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events oral lesions, blisters, altered taste, mouth burning, raw mouth, sore throat and swollen tongue was not resolved at the time of the report.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Lip disorder, Lip pruritus, Lip swelling
Clinical narrative: Small raised bumps on lip; Swelling and itchiness on lip; Itchiness on lip; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2588) via an unspecified route of administration in right arm on 18Sep2021 at 10:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3181) via an unspecified route of administration in right arm on 26Aug2021 at 11:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. On 21Sep2021 at 07:00, the patient experienced small raised bumps on lip, followed by swelling and itchiness on lip. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events small raised bumps on lip, swelling and itchiness on lip was not resolved at the time of report.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Arthropathy, Dizziness, Fatigue, Headache, Pain in extremity
Clinical narrative: Weak knees; Fatigue; Pins and needles feeling throughout entire body; Vomiting; Dizzy; Headache; Extreme pain in right arm; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 20Sep2021 at 10:15 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety, depression, inflammation of the shoulder, ridiculopathy (radiculopathy) in her arms. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 26Aug2021 at 17:15 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. On 21Sep2021 at 00:15, the patient experienced weak knees, fatigue, pins and needles feeling throughout her entire body, vomiting 14 hours after vaccine for 7 hours, dizzy, headache and extreme pain in her right arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events weak knees, fatigue, pins and needles feeling throughout her entire body, dizzy, headache and extreme pain in right arm were not resolved, while that of the event vomiting was resolved on 21Sep2021 at 07:15, after the duration of 7hours.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Vomiting
Clinical narrative: Weak knees; Fatigue; Pins and needles feeling throughout entire body; Vomiting; Dizzy; Headache; Extreme pain in right arm; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 20Sep2021 at 10:15 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety, depression, inflammation of the shoulder, ridiculopathy (radiculopathy) in her arms. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 26Aug2021 at 17:15 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. On 21Sep2021 at 00:15, the patient experienced weak knees, fatigue, pins and needles feeling throughout her entire body, vomiting 14 hours after vaccine for 7 hours, dizzy, headache and extreme pain in her right arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events weak knees, fatigue, pins and needles feeling throughout her entire body, dizzy, headache and extreme pain in right arm were not resolved, while that of the event vomiting was resolved on 21Sep2021 at 07:15, after the duration of 7hours.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Amenorrhoea
Clinical narrative: No menstrual cycle since she received the vaccine; This is a spontaneous report from a non-contactable consumer. A 27-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On an unknown date in 2021, the patient had no menstrual cycle since she received the vaccine and it had been 2.5 months. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the event. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the event no menstrual cycle since she received the vaccine was unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain
Clinical narrative: body aches, achy; severe headache; chills; This is a spontaneous report from a contactable other healthcare professional (medical technologist, patient) from a Pfizer Sponsored Program. A 70-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/lot number and expiration date were not reported), via an unspecified route of administration on 17Feb2021 as dose 2, single for COVID-19 immunisation. Medical history included migraine from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient experienced quite a few body aches, achy, severe headache and chills on an unspecified date in 2021. The outcome of the events was unknown. The patient was querying if she can take her migraine medication (Rizatriptan 10mg).   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Nausea, Pain in extremity
Clinical narrative: Diarrhea; sore arm; Nausea; really tired; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored program. A 55-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number: EM9809, Expiration Date: not reported), via an unspecified route of administration, administered in right arm on 14Feb2021 at 14:00 (at the age of 55 years old) as dose 1, single for COVID-19 immunisation. Medical history included unspecified allergies and asthma - both diagnosed as a kid from an unknown date. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Historical vaccine included flu shot given on an unspecified date in Oct2020 (at the age of 55 years old) for immunization. On 15Feb2021, the patient experienced sore arm, nausea and had been really tired. Then on 16Feb2021, the patient had diarrhea and was nausea but no fever. The events did not require visit to an emergency room nor to Physician Office Visit. The patient was asking if she should expect the same side effects during the second dose and if it will be worse and was also asking if these maybe related to her allergies. Furthermore, the patient heard that the symptoms after the second dose could be worse and wanted to know what she can expect, if that is true. The patient recovered from diarrhea on 16Feb2021 and was recovering all other events.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: body aches; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored program. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/lot number and expiration date were not reported), via an unspecified route of administration on 09Feb2021 as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced body aches after the first dose on an unspecified date. Event was reported as non-serious. It was reported that the patient isn't getting the "real deal", she does not even have redness, she does not feel sick at all. She wanted to know if it is ok and if she could take the second dose on 03Mar2021 as scheduled. The patient wanted to know if she is protected by the vaccine or not and was querying when she will be tested negative after the vaccine. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in jaw, Upper respiratory tract congestion
Clinical narrative: congestion in his throat; pain in the jaw that radiated from his jawbone up to the ear; This is a spontaneous report from a contactable consumer (patient). A 76-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection; Lot Number: EL9266, Expiration Date not reported) via an unspecified route of administration, administered in the right arm on 14Feb2021 08:00 (at the age of 76-years-old), as dose 1, single for COVID-19 immunisation. Medical history included stroke from 2017 and ongoing. Concomitant medications included warfarin taken for stroke from 2017 and ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and no other vaccines was administered with COVID-19 vaccine. The patient experienced pain in the jaw that radiated from his jawbone up to the ear on 15Feb2021 and congestion in his throat on 17Feb2021. Patient reported he had a lot of congestion in his throat that doesn't go up or down. He did not have any other problems and nor was he not feeling well. At night things were worse for him.. He reported that he was scheduled to get the second dose 07Mar2021. Patient took paracetamol (TYLENOL) every 8 hours as a result of pain in the jaw. Event did not result to either physician office or emergency room visit. The outcome of events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms
Clinical narrative: crazy cramps in her legs and they hurt. It comes and goes more in the left leg than the right leg; This is a spontaneous report from a contactable consumer (patient). A 72-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection; Lot Number: EL9267, Expiration Date not reported) via an unspecified route of administration, administered in the left arm on 10Feb2021, between 10:30 to 11:30 (at the age of 72-years-old), as dose 1, single for COVID-19 immunisation. Medical history included HIV (reported as It is undetectable. She was diagnosed in 1995 or 1996). There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and no other vaccines was administered with COVID-19 vaccine. The patient experienced crazy cramps in her legs and they hurt. it comes and goes more in the left leg than the right leg on 11Feb2021. It was reported that it was in the muscle and in the back of the thighs. Patient was inquiring on how to stop this. Her next dose was scheduled on 03Mar2021. Event did not result to either physician office or emergency room visit. The outcome of event was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Back injury
Clinical narrative: hurt her back when she reached down to pick up something / back was hurting; This is a spontaneous report from a contactable consumer (patient). A 59-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number and Expiration date were not reported), via an unspecified route of administration (administered on the right arm) on 29Jan2021 (at the age of 59-years-old) as dose 1, single for COVID-19 immunisation. Medical history included ongoing arthritis in her back (diagnosed about 5 years ago). The patient's concomitant medications were not reported. The patient has no other vaccines on the same day of COVID vaccine. The patient hurt her back when she reached down to pick up something / back was hurting on 17Feb2021. The patient further reported that she has a question concerning if a medication will impact her next COVID vaccine dose. She had the first dose on 29Jan2021 and was scheduled for her second dose tomorrow. The patient stated that she hurt her back yesterday and the orthopedic doctor prescribed her a Methylpredisone Pack. She stated that she has not started it yet, because she saw that it was contraindicated with vaccines, so she was just wondering if that was accurate and if she should wait to start it until after taking her 2nd dose. The outcome of the event was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Fatigue, Hunger
Clinical narrative: altered taste-metallic taste; hungry; tired; This is a spontaneous report from a contactable consumer (patient) received via Information Team. An 83 (unit not specified) female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration on 22Jan2021 08:00 (Batch/Lot number: not reported) as dose 1, single for COVID-19 immunisation. The patient's medical history included immunocompromised. Concomitant medications were not reported. On 22Jan2021, that evening, the patient experienced altered taste-metallic taste which went away the next morning. The patient was also very hungry and tired after the dose on unspecified dates in 2021. The patient recovered from altered taste-metallic taste on 23Jan2021 while the outcome of the other events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Migraine, Pain
Clinical narrative: Chills; migraine; dizziness; body aches; This is a spontaneous report from a contactable healthcare professional (patient). A non-pregnant 45-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot number: El9267), intramuscularly, administered in right arm on 19Feb2021 at 15:30 (age at vaccination was 45-year-old) as dose number unknown, single for COVID-19 immunization. The patient's medical history included ulcerative colitis. Concomitant medications were not reported. The patient did not receive any other vaccine within 4 weeks. Prior to vaccination, the patient has not been diagnosed with COVID-19 and post vaccination, the patient has not been tested for COVID-19. The facility type where COVID-19 vaccine was administered was reported as workplace clinic. On 20Feb2021, the patient experienced chills, migraine, dizziness, and body aches. No therapeutic measures were taken as a result of the events. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypoaesthesia, Muscle twitching, Nasal discomfort
Clinical narrative: Twitching of tongue; intermittent right hand numbness; nasal discomfort; Headache; This is a spontaneous report from a contactable consumer (patient). A 65-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in arm left on 20Feb2021 10:00 (at the age of 65-years-old) as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took acetylsalicylic acid (ASPIRIN) and experienced known allergies. The patient was not pregnant at time of vaccination. The patient did not have COVID-19 prior to the vaccination. No COVID-19 tested post vaccination. The patient was not received other vaccine in four weeks and other medications in two weeks. The patient experienced twitching of tongue, intermittent right hand numbness, nasal discomfort and headache on 20Feb2021 20:00. No treatment was received for the adverse events. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Pain in extremity
Clinical narrative: Muscle soreness; Arm tenderness; Headache; Fatigue; This is a spontaneous report from a non-contactable consumer (patient). A non-pregnant 27-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot number: EL9267), via an unspecified route of administration, administered in left arm on 12Feb2021 at 15:00 (age at vaccination was 27-year-old) as dose 1, single for COVID-19 immunization. The patient's medical history included known allergies to Cephalosporins and sulfas. Concomitant medications (other medications in two weeks) included desvenlafaxine succinate (PRISTIQ), ibuprofen and multivitamins (as reported); all from an unspecified date and unknown indication. The patient did not receive any other vaccine within 4 weeks. Prior to vaccination, the patient has not been diagnosed with COVID-19 and post vaccination, the patient has not been tested for COVID-19. The facility type where COVID-19 vaccine was administered was reported as hospital. On 12Feb2021, the patient experienced muscle soreness, arm tenderness, headache, and fatigue. It was reported that muscle soreness and arm tenderness lasted for 3 days. No therapeutic measures were taken as a result of the events. The outcome of the events muscle soreness and arm tenderness was recovered on 15Feb2021 while for headache and fatigue was recovered on Feb2021.  No follow-up attempts are possible. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Dry throat, Fatigue, Head discomfort, Myalgia
Clinical narrative: dry throat; Pressure on my head; muscle pain; tiredness; This is a spontaneous report from a non-contactable consumer (patient). A 26-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 19Feb2021 at 16:00 (at the age of 26-years-old) (Batch/Lot number was not reported) as dose number unknown, single for COVID-19 immunisation. The patient's medical history (also reported medical history as no) and concomitant medications were not reported. The patient was not pregnant at the time of the events. The patient has no known allergies.  The patient did not receive other vaccine in four weeks. The patient did not have COVID prior to vaccination and had not been tested for COVID post-vaccination. On an unspecified date, the patient experienced pressure on her head, muscle pain, tiredness, and dry throat. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Lymph node pain, Lymphadenopathy, Tremor
Clinical narrative: chills to the point of uncontrollable shaking with no fever present; chills to the point of uncontrollable shaking with no fever present; Armpit lymph node was swollen and very painful; pain in the armpit on the side of the vaccine/ armpit lymph node was swollen and very painful/ could not lift arm without pain in lymph node located in armpit; This is a spontaneous report from a non-contactable other healthcare professional (patient) received via COVID19 Reporting. A 27-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EC9266), via an unspecified route of administration on 18Feb2021, at 12:00 (at the age of 27 years old) as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Twelve hours after vaccination (on 19Feb2021), the patient began experiencing chills to the point of uncontrollable shaking, with no fever present. On 19Feb2021, she also began feeling pain in the armpit on the side of the vaccine. The armpit lymph node was swollen and very painful. She could not lift arm without pain in lymph node located in armpit. The patient was not diagnosed with COVID-19 prior to vaccination and she has not been tested for COVID-19 since the vaccination. No therapeutic measures were taken as a result of the events. The patient has not recovered from the events.   No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: Injection site reaction; This is a spontaneous report from a non-contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced injection site reaction on an unspecified date. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm was sore; This is a spontaneous report from a contactable consumer (patient's wife). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for COVID-19 immunisation. Medical history included Crohn's disease. The patient's concomitant medications were not reported. The patient experienced arm was sore on an unspecified date. The outcome of event was unknown.  No follow-up attempts are possible; information on the lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: pain; This is a spontaneous report from a non-contactable consumer (patient's sister) received via a Pfizer-sponsored program. A female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration on 16Feb2021 (Batch/Lot number: not reported) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date in 2021, the patient experienced pain after having her first dose of the vaccine. The reporter wanted to know if the patient could take ibuprofen (MOTRIN). The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain
Clinical narrative: Mild headache; Nausea; mild aches throughout most of my body; This is a spontaneous report from a non-contactable consumer (patient).   A 30-year-old male patient received BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EL3247) via an unspecified route of administration, administered in Arm Left on 19Feb2021 14:00 (at the age of 30 years old) as dose 2, single for COVID-19 immunisation. The patient's medical history reported as none and concomitant medications were not reported. No known allergies. The patient previously received BNT162B2 (Batch/Lot number: EL3247) administered in arm left on 29Jan2021 14:00 (at the age of 30 years old) as dose 1, single for COVID-19 immunisation. On 20Feb2021 08:00, the patient experienced mild headache, nausea, and mild aches throughout most of body, no fever (as reported). The facility type vaccine was reported as other. Patient had no other vaccine in four weeks. Patient had no COVID prior vaccination and not COVID tested post vaccination. . There was no treatment for adverse events. The outcome of the events was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Neck pain
Clinical narrative: Severe neck painSevere back pain; Severe back pain; This is a spontaneous report from a non-contactable healthcare professional. A 40-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), intramuscular, administered in left arm on 16Feb2021 at 15:00 (Batch/Lot number was not reported) (at the age of 40-years-old) as dose 2, single for COVID-19 immunisation. Medical history included allergy to Sulfa. The patient was not pregnant at time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 post vaccination. Concomitant medications included triamcinolone acetonide (NASACORT) taken for an unspecified indication, start and stop dates were not reported. The patient did not receive any other vaccines within 4 weeks prior to COVID-19 vaccine. The patient previously received the first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular, administered in left arm on 26Jan2021 at 15:00 (Batch/Lot number was not reported) (at the age of 40-years-old) for COVID-19 immunisation. The patient experienced severe neck pain and severe back pain on 20Feb2021. The patient received no treatment for the events. The adverse events resulted to none. The outcome of events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Swelling
Clinical narrative: All 11 of the 12 listed.  Also shot is still swollen and itching; All 11 of the 12 listed.  Also shot is still swollen and itching; This is a spontaneous report from a contactable Other HCP(Patient). A 72-years-old non pregnant female patient received first dose of bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Solution for injection; lot number: unknown), via an unspecified route of administration on 05Mar2021 at 10:00 administered in Arm Left as a single dose for COVID-19 immunisation at Hospital. Medical history included Lung cancer, COVID-19 (all from an unknown date and unknown if ongoing). Concomitant medication(s) included levothyroxine sodium (THYROXINE) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Post vaccination, the patient has not been tested for COVID-19. The patient had no allergies. On 05Mar2021 at 19:00 PM, the patient experienced all 11 of the 12 listed. Also shot is still swollen and itching. No treatment was given for the events. The outcome of the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Flushing, Headache, Nausea, Pain
Clinical narrative: nausea; achy; feeling tired; flushed on face; neck broke out in hives; dull headache; itching; This is a spontaneous report from a contactable consumer (patient). A 55-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number EN6205 and expiration date not reported), via an unspecified route of administration, administered in Arm Left, on 07Mar2021 11:45 (at the age of 55-year-old), as dose 1, single, for COVID-19 immunisation in hospital. Patient was not pregnant at the time of vaccination. Medical history included high blood pressure, arthritis. Concomitant medications included amlodipine besylate; levothyroxine; lovastatin. Allergies included Sulfa, Lisinopril, Adhesive, Vancomycin. The patient previously took lisinopril and vancomycin and experienced allergies. Patient did not receive other vaccine in four weeks. Patient was not diagnosed with COVID prior vaccination and was not tested COVID post vaccination. On 07Mar2021 12:15, 30 minutes after vaccination, became flushed on face and neck broke out in hives, later dull headache and itching. On 08Mar2021, next morning, the patient experienced nausea, achy and feeling tired. Took Benadryl for itching. The outcome for the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: nausea; achy; feeling tired; flushed on face; neck broke out in hives; dull headache; itching; This is a spontaneous report from a contactable consumer (patient). A 55-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number EN6205 and expiration date not reported), via an unspecified route of administration, administered in Arm Left, on 07Mar2021 11:45 (at the age of 55-year-old), as dose 1, single, for COVID-19 immunisation in hospital. Patient was not pregnant at the time of vaccination. Medical history included high blood pressure, arthritis. Concomitant medications included amlodipine besylate; levothyroxine; lovastatin. Allergies included Sulfa, Lisinopril, Adhesive, Vancomycin. The patient previously took lisinopril and vancomycin and experienced allergies. Patient did not receive other vaccine in four weeks. Patient was not diagnosed with COVID prior vaccination and was not tested COVID post vaccination. On 07Mar2021 12:15, 30 minutes after vaccination, became flushed on face and neck broke out in hives, later dull headache and itching. On 08Mar2021, next morning, the patient experienced nausea, achy and feeling tired. Took Benadryl for itching. The outcome for the events was recovering.  No follow-up attempts are possible. No further information is expected.